EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Diagnostic utility of FGF-23 in mineral bone disorder during chronic kidney disease

Luisa Albanese, Gemma Caliendo, Giovanna D'Elia, Luana Passariello, Anna Maria Molinari, Claudio Napoli, Maria Teresa Vietri

Journal of Circulating Biomarkers · 08.01.2022 · 11 · 1-4

DOI: 10.33393/jcb.2022.2328 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Circulating Biomarkers, online erschienen am 08.01.2022. Verfasst von Luisa Albanese und 6 weiteren Autor:innen. Beteiligte Einrichtung: Unity of Clinical and Molecular Pathology, AOU, University of Campania "Luigi Vanvitelli", Naples - Italy. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Our data confirm that intact fibroblast growth factor 23 (iFGF-23) concentration is increased in patients with chronic kidney disease (CKD) and that it increases with disease progression (stages I-V). Therefore, iFGF-23 could be considered an early biomarker in the course of chronic kidney disease-mineral bone disorder (CKD-MBD), which has several aspects that make it potentially useful in clinical practice. The availability of an automated method for iFGF-23 assay may represent an added value in the management of the patient with CKD-MBD already from the early stages of the disease, before the increase of the routinely used laboratory parameters, 1-84 parathyroid hormone (PTH) and 25-OH-vitamin D (25-OH-vitD), which occur in more advanced stages of the disease.

Autor:innen und Institutionen

  • Unity of Clinical and Molecular Pathology, AOU, University of Campania "Luigi Vanvitelli", Naples - Italy.
  • Department of Precision Medicine, University of Campania "Luigi Vanvitelli", Naples - Italy.
  • Department of Advanced Medical and Surgical Sciences (DAMSS), University of Campania "Luigi Vanvitelli", Naples - Italy.
  • Clinical Department of Internal Medicine and Specialistic Units, AOU, University of Campania "Luigi Vanvitelli", Naples - Italy.

Zitieren

APA

Albanese, L., Caliendo, G., D'Elia, G., Passariello, L., Molinari, A. M., Napoli, C., & Vietri, M. T. (2022). Diagnostic utility of FGF-23 in mineral bone disorder during chronic kidney disease. Journal of Circulating Biomarkers, 11, 1-4. https://doi.org/10.33393/jcb.2022.2328

Vancouver

Albanese L, Caliendo G, D'Elia G, Passariello L, Molinari AM, Napoli C, et al. Diagnostic utility of FGF-23 in mineral bone disorder during chronic kidney disease. Journal of Circulating Biomarkers. 2022;11:1-4. doi:10.33393/jcb.2022.2328

BibTeX
@article{Albanese2022,
  author = {Albanese, Luisa and Caliendo, Gemma and D'Elia, Giovanna and Passariello, Luana and Molinari, Anna Maria and Napoli, Claudio and Vietri, Maria Teresa},
  title = {Diagnostic utility of FGF-23 in mineral bone disorder during chronic kidney disease},
  journal = {Journal of Circulating Biomarkers},
  year = {2022},
  volume = {11},
  pages = {1--4},
  doi = {10.33393/jcb.2022.2328}
}
Kostenlos starten →